Skip to content

Molecular, Metabolomic and Nutritional Changes After Metabolic Surgery

Molecular, Metabolomic and Nutritional Changes After Metabolic Surgery Among Obese Diabetic Patients and Biomarkers of Different Diabetes Status.

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05322551
Acronym
MoMen
Enrollment
102
Registered
2022-04-12
Start date
2022-06-24
Completion date
2024-12-31
Last updated
2022-09-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabete Type 2, Obesity; Endocrine, PreDiabetes

Keywords

Bariatric surgery, Metabolic surgery

Brief summary

Obesity is a major risk factor for Type 2 Diabetes (T2D) and cardiovascular diseases, such as hypertension and dyslipidemia. Recently, weight loss surgery (i.e., metabolic or bariatric surgery) has been shown to result in very good long-term glycemic control in patients with T2D and obesity. However, knowledge and data on molecular levels and metabolomics are still limited. This study will fill in these gaps and provide potential biomarkers for T2D. Lifestyle and dietary practices (LDP) influence the clinical outcome and metabolites in T2D. Although the roles of LDP is critical in ensuring optimal clinical outcomes, data is still limited especially on relating the LDP and metabolomics in T2D.

Detailed description

Study design This is a prospective single centre study to explore molecular aspects and metabolomic changes among 102 obese individuals of different diabetes status, undergoing metabolic surgery, which is currently performed in Hospital Kuala Lumpur, Malaysia. Serial measurements of the selected markers will be made pre-operative (baseline), at 6 and 12 months follow up after surgery. Twenty (20) healthy individuals will be recruited as controls. Study population All subjects with obesity (Body Mass Index ≥ 30kg/m\^2 \[WHO classification\])) and diagnosed with pre-diabetes, T2D and non-diabetic (healthy) who are undergoing metabolic surgery at Hospital Kuala Lumpur will be recruited. All patients referred by endocrinologists who are eligible and fulfill the inclusion and exclusion criteria for metabolic surgery will be included in the study until the sample size is achieved. Routinely, all patients will need to pay a visit to the clinic at 1, 2, 4 weeks after surgery, then 3, 6, 9, 12, 18, 24 months and after that, a life-long annual visit. Therefore, visit 6- and 12-month will be utilized for study follow-ups. Metabolic surgery The two most standard metabolic surgical procedures performed at Hospital Kuala Lumpur are laparoscopic sleeve gastrectomy and laparoscopic Roux en Y gastric bypass (RYGB). All the procedures are performed laparoscopically using 5-ports technique.

Interventions

None listed

Sponsors

Universiti Putra Malaysia
CollaboratorOTHER
Ministry of Health, Malaysia
Lead SponsorOTHER_GOV

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

Patients' Inclusion Criteria * BMI \> 30kg/m2 * Men and women * Ages 18-65 years old * Diabetes status (non diabetic, pre diabetes and diabetes) * Patients who will undergo metabolic surgery Healthy individuals' Inclusion Criteria * BMI \< 30kg/m2, * Men and women * Ages 18-65 years old * No diabetes * No pre diabetes * No other co-morbidities (high total cholesterol, high triglycerides, high blood pressure)

Exclusion criteria

Patients'

Design outcomes

Primary

MeasureTime frameDescription
Changes in lipid related biochemical parameters6 monthsChanges in triglyceride, total cholesterol, LDL cholesterol, HDL cholesterol levels in mmol/L
HbA1c changes6 monthsHbA1c changes measured in percentage
Changes of metabolites profile6 monthsChanges of serum diabetes-related metabolites using Nuclear Magnetic Resonance (NMR)
Body weight changes6 monthsBody weight changes
Body mass index (BMI) changes6 monthsBody mass index changes measured in kg/m\^2 (weight in kilograms, height in meters)
Body Fat Percentage changes6 monthsBody Fat Percentage changes measured in percentage
Fasting Blood Glucose changes6 monthsFasting Blood Glucose changes measured in mmol/L

Secondary

MeasureTime frameDescription
Dietary Intake changesAt baseline, month 6 and month 12Dietary intake changes measured by Food Frequency Questionnaire (FFQ)
Quality of Life changesAt baseline, month 6 and month 12Quality of Life score measured by Obesity and Weight-Loss Quality of Life (OWLQOL ) questionnaire

Countries

Malaysia

Contacts

Primary ContactFazliana Mansor, PhD
fazliana.m@moh.gov.my+60162280081

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026